Back to top

Fate Therapeutics announces FDA clearance of FT839 IND application

Fate Therapeutics (FATE) announced that the FDA has cleared its investigational new drug, or IND, application for FT839, the company’s next-generat...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Fate Therapeutics, Inc. (FATE)